Cannabis News

Tilray Expands Medical Marijuana Product Offering In Australia, Launches Cannabis E-Learning Platform – Medical Marijuana Program Connection


Marijuana Giant Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) announced on Tuesday expanding its medical cannabis product offering in Australia and the launch of a new online medical cannabis learning platform for healthcare providers.

“Tilray is transforming the industry globally through our highly scalable footprint and portfolio of diverse cannabis products,” said Denise Faltischek, international manager and director of strategy. “Having listened to patient feedback and learned from our operations in Germany, we are excited to introduce new products to Australia that meet consumer needs.”

The company’s product offering in Australia, approved under the Therapeutic Goods Administration (TGA) Special Access and Authorized Prescriber Program, is centered around its whole flower options ranging from balanced 1:1 whole flower (THC 10 CBD 10), of which midrange (17) and High THC (25) varieties of 15g sachet Whole flower of medical cannabis GMP certified.

His new teaching on medical cannabis platform for healthcare professionals is built on the importance of understanding the benefits derived from using medical cannabis. To date, Tilray has successfully launched several medical cannabis workshops in Australia and New Zealand, training hundreds of healthcare professionals in 2021.

“We are committed to providing patients in need with reliable access to pharmaceutical-grade medical cannabis products and we are pleased to expand…

Original author link click here to read the full story.

Marijuana Giant Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) announced on Tuesday expanding its medical cannabis product offering in Australia and the launch of a new online medical cannabis learning platform for healthcare providers.

“Tilray is transforming the industry globally through our highly scalable footprint and portfolio of diverse cannabis products,” said Denise Faltischek, international manager and director of strategy. “Having listened to patient feedback and learned from our operations in Germany, we are excited to introduce new products to Australia that meet consumer needs.”

The company’s product offering in Australia, approved under the Therapeutic Goods Administration (TGA) Special Access and Authorized Prescriber Program, is centered around its whole flower options ranging from balanced 1:1 whole flower (THC 10 CBD 10), of which midrange (17) and High THC (25) varieties of 15g sachet Whole flower of medical cannabis GMP certified.

His new teaching on medical cannabis platform for healthcare professionals is built on the importance of understanding the benefits derived from using medical cannabis. To date, Tilray has successfully launched several medical cannabis workshops in Australia and New Zealand, training hundreds of healthcare professionals in 2021.

“We are committed to providing patients in need with reliable access to pharmaceutical-grade medical cannabis products and we are pleased to expand…

source link



#Tilray #Expands #Medical #Marijuana #Product #Offering #Australia #Launches #Cannabis #ELearning #Platform #Medical #Marijuana #Program #Connection

Related Posts

Leave a Reply